Denmark on Wednesday became 1st European country to completely halt the use of AstraZeneca jab which was renamed Vaxzevria last month. This follows investigations that linked the jabs to rare blood clotting. In a statement on Wednesday, the Danish Health Authority announced it had “decided to continue the rollout at this time without AstraZeneca,” citing “a possible link between very rare cases of unusual blood clots, bleeding, low blood platelets counts” and the jabs. Results of investigations into the AstraZeneca-associated blood clots “showed real and serious side-effects,” Danish health agency head Soren Brostrom told a news briefing.
Danish people who have already received their first AstraZeneca jab will be invited to get vaccinated with another provider. Several European countries decided to give the jab only to older people. The European Union’s drug watchdog said last week the risk of dying from COVID-19 was much greater than the risk of mortality from rare side effects, but left it to individual states to make their own risk assessments and decide how to administer the vaccine. Denmark is in the process of easing restrictions after its daily COVID-19 infection rate slowed to 500-600 from several thousand in December.